Novartis Pharmaceuticals is classified as operating in the Pharmaceutical Preparation Manufacturing industry, NAICS Code 325412.
Trademark Applications
Trademark applications show the products and services that Novartis Pharmaceuticals is developing and marketing.
Novartis Pharmaceuticals doesn't have any recent trademark applications, indicating Novartis Pharmaceuticals is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
DYNACIRC CR pharmaceutical preparation; namely, a calcium antagonist used in the treatment of hypertension, angina and congestive heart failure
05/01/1991
LOTENSIN ANTIHYPERTENSIVE
02/27/1989
HYPOTEARS OPHTHALMIC PREPARATIONS OR EYE DROPS
02/03/1986
See all trademarks and details in the Full Report.
Market Share of Novartis Pharmaceuticals's Largest Competitors
A competitive analysis shows these companies are in the same general field as Novartis Pharmaceuticals, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Novartis Pharmaceuticals.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as Novartis Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.